Showing 921 - 940 results of 115,704 for search '(( a non decrease ) OR ( 5 ((wt decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.41s Refine Results
  1. 921
  2. 922
  3. 923
  4. 924
  5. 925
  6. 926
  7. 927
  8. 928

    NAC prevents VMH GI neuron activation by decreased glucose. by Xavier Fioramonti (371172)

    Published 2013
    “…(B) Percentage of VMH GI neurons from S<sup>3</sup>S or I<sup>3</sup>S rats pre-treated or not with NAC which depolarized in response to a 2.5–0.7 mM glucose decrease quantified using changes in FLIPR-MPD fluorescence intensity. *: p<0.05 (Two-way ANOVA; group differences were determined by One-Way ANOVA followed by Bonferoni post-hoc test).…”
  9. 929
  10. 930

    As the protein lifetime decreases, a trade-off between dynamical and mechanistic error determines fidelity. by Clive G. Bowsher (395875)

    Published 2013
    “…<p>We consider a 2-stage model of gene expression with the input, , equal to the current rate of transcription, and the signal of interest . …”
  11. 931

    Hematopoietic potential decreases in ESC with down-regulation of junction molecules. by Basha L. Stankovich (207031)

    Published 2011
    “…CD45 expression was analyzed flow cytometrically using anti-CD45 conjugated to PerCP-Cy5.5. Non-viable cells were excluded based on DAPI fluorescence. …”
  12. 932
  13. 933

    Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype. by Stephanie L. Easter (662168)

    Published 2014
    “…Values are means +/− standard error (n = 6 MMTV-Wnt1, 3 fields per tumor; n = 5 MMTV-Wnt1;MMTV-Wnt5a, 3 fields per tumor). MMTV-Wnt1;MMTV-Wnt5a tumors demonstrated a significant decrease in K6-expressing cells as measured by T-test (* = p<0.05).…”
  14. 934
  15. 935
  16. 936
  17. 937
  18. 938

    Image 5_Behavioral and biochemical changes associated with the analgesic effects of (2R,6R)-hydroxynorketamine alone and in combination with meloxicam following disk puncture in mi... by Vaskar Das (21529538)

    Published 2025
    “…Our finding supports further study of the clinical potential of (2R,6R)-Hydroxynorketamine as a non-opioid analgesic for discogenic back pain.…”
  19. 939
  20. 940